News

Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...
One estimate of the profit hit from Trump's executive order on drug pricing
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
Merck’s New Keytruda Shot Is a Rare Real-Time ‘Product Hop’ (1)
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
Pharma Stocks Recover From Initial Shock of Trump's Drug Pricing Order
Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...
Trump signs executive order setting 30-day deadline for drugmakers to lower prescription drug costs
The order calls on the health department, led by Robert F. Kennedy Jr., to broker new price tags for drugs over the next ...
Trump promises to slash drug costs, tying US prices to those paid abroad
The order directs U.S. Trade Representative Jamieson Greer and Commerce Secretary Howard Lutnick to ensure other nations do ...